BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16528372)

  • 1. Fibrillin expression and localization in various types of carcinomas of the thyroid gland.
    Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Litsiou H; Sozopoulos E; Balafoutas D; Patsouris E
    Mod Pathol; 2006 May; 19(5):695-700. PubMed ID: 16528372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.
    Moretti S; Menicali E; Voce P; Morelli S; Cantarelli S; Sponziello M; Colella R; Fallarino F; Orabona C; Alunno A; de Biase D; Bini V; Mameli MG; Filetti S; Gerli R; Macchiarulo A; Melillo RM; Tallini G; Santoro M; Puccetti P; Avenia N; Puxeddu E
    J Clin Endocrinol Metab; 2014 May; 99(5):E832-40. PubMed ID: 24517146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf-1 kinase inhibitory protein expression in thyroid carcinomas.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Endocr Pathol; 2010 Dec; 21(4):253-7. PubMed ID: 20734161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
    Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human beta-defensins-1-4 in thyroid cancer cells and new insight on biologic activity of hBD-2 in vitro.
    Zhuravel OV; Gerashchenko OL; Khetsuriani MR; Soldatkina MA; Pogrebnoy PV
    Exp Oncol; 2014 Sep; 36(3):174-8. PubMed ID: 25265350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
    Burrows N; Resch J; Cowen RL; von Wasielewski R; Hoang-Vu C; West CM; Williams KJ; Brabant G
    Endocr Relat Cancer; 2010 Mar; 17(1):61-72. PubMed ID: 19808899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.
    Ferru A; Fromont G; Gibelin H; Guilhot J; Savagner F; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
    Br J Cancer; 2006 Dec; 95(12):1670-7. PubMed ID: 17117177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
    Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
    Weber T; Amann K; Weckauf H; Lacroix J; Weitz J; Schönfuss T; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
    World J Surg; 2002 Feb; 26(2):148-52. PubMed ID: 11865340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis.
    Choe W; Kim S; Hwang TS; Lee SS
    Pathol Int; 2003 Jul; 53(7):434-9. PubMed ID: 12828608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene Fusions in Thyroid Cancer.
    Yakushina VD; Lerner LV; Lavrov AV
    Thyroid; 2018 Feb; 28(2):158-167. PubMed ID: 29281951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of p63 expression in thyroid neoplasm].
    Qian M; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(19):888-90, 893. PubMed ID: 19160863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
    Rodríguez-Rodero S; Fernández AF; Fernández-Morera JL; Castro-Santos P; Bayon GF; Ferrero C; Urdinguio RG; Gonzalez-Marquez R; Suarez C; Fernández-Vega I; Fresno Forcelledo MF; Martínez-Camblor P; Mancikova V; Castelblanco E; Perez M; Marrón PI; Mendiola M; Hardisson D; Santisteban P; Riesco-Eizaguirre G; Matías-Guiu X; Carnero A; Robledo M; Delgado-Álvarez E; Menéndez-Torre E; Fraga MF
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2811-21. PubMed ID: 23666970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas.
    Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF
    Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.